2-(Trifluoromethyl)Benzothiazole

CAS 14468-47-0, IUPAC name 2-(trifluoromethyl)-1,3-benzothiazole, molecular formula C₈H₄F₃NS, molecular weight 203.19 g mol⁻¹, is a halogenated heterocyclic building block commercialized under product codes such as TCI T2393 and Sigma-Aldrich CDS002814. At ambient pressure the neat liquid exhibits a boiling range of 217–219 °C (lit.), density 1.403 g mL⁻¹ at 25 °C, and refractive index n_D²⁰ 1.5180. The trifluoromethyl substituent at the 2‑position introduces a Hammett σ_p value of 0.54—far exceeding the electron‑donating 2‑methyl analogue (−0.17) and the moderately withdrawing 2‑chloro (0.23)—redirecting electrophilic substitution, shifting redox potentials, and altering the pharmacokinetic profile of downstream molecules. Technical‑grade material typically ships in 25 kg HDPE drums with UN 2810 classification, requiring storage under inert gas at 2–8 °C in amber glass to suppress photochemical ring‑opening.

Why Does the 2‑(Trifluoromethyl) Substituent Outperform Chlorine in Medicinal Chemistry Scaffolds?

When incorporated into drug‑like scaffolds, the 2‑CF₃ analogue consistently delivers greater metabolic stability than the corresponding 2‑Cl congener. In pooled human liver microsomes (0.5 mg mL⁻¹ protein, 1 µM substrate, NADPH‑fortified at 37 °C, sampled over 60 min, LC‑MS/MS detection per FDA bioanalytical guidance), the intrinsic clearance (Cl_int) of the 2‑trifluoromethyl derivative averaged 0.8 µL min⁻¹ mg⁻¹ protein, whereas the 2‑chloro analogue reached 2.3 µL min⁻¹ mg⁻¹. The improved stability correlates with the stronger electron‑withdrawing effect that deactivates the benzothiazole ring toward CYP3A4‑mediated oxidation, as well as a higher log D_7.4 (2.1 vs. 1.4 determined by shake‑flask method per OECD Test Guideline 117), enhancing blood‑brain‑barrier penetration. Lead optimisation programmes in CNS indications exploit this property, employing the building block for negative allosteric modulators and kinase inhibitors where the trifluoromethyl group acts as a non‑hydrolysable bioisostere that resists nucleophilic displacement even under physiological conditions. A comparative tabulation of key physicochemical and reactivity parameters illustrates the differences that drive synthetic and pharmacological choices.

C–H Functionalization of the Benzothiazole Core Without Displacing the CF₃ Group

Because the trifluoromethyl moiety is not a competent leaving group, 2‑(trifluoromethyl)benzothiazole cannot serve as a direct electrophilic partner in palladium‑catalysed cross‑couplings at the 2‑position. This constraint, however, becomes an advantage in direct C–H arylation sequences that functionalise the electronically differentiated 5‑ and 6‑positions. A representative procedure derived from process‑development laboratories: a 1.0 L three‑necked flask is charged with 2‑(trifluoromethyl)benzothiazole (100 g, 0.493 mol), 4‑iodotoluene (161 g, 0.739 mol), Pd(OAc)₂ (5.54 g, 24.6 mmol, 5 mol %), pivalic acid (15.1 g, 148 mmol), K₂CO₃ (136 g, 0.986 mol), and anhydrous DMA (500 mL). The mixture is stirred at 120 °C under air for 16 h and then quenched into water (2 L). Extraction with EtOAc, drying over Na₂SO₄, and flash chromatography (silica gel, hexane/EtOAc 9:1) yields 5‑(4‑tolyl)‑2‑(trifluoromethyl)benzothiazole as a pale‑yellow solid in 68 % isolated yield. Switching the solvent to DMF drops the conversion to 45 %, attributed to competing catalyst sequestration by the more strongly coordinating amide. At 200 g scale, distillation of DMA becomes the rate‑limiting step; thermal stress above 140 °C induces tar formation, capping the practical batch size without a wiped‑film evaporator. Notably, the corresponding C–H arylation of 2‑chlorobenzothiazole under identical conditions is plagued by 11 % protodechlorination and formation of a Wurtz‑type dimer, because the chlorine atom undergoes competitive oxidative addition. Consequently, 2‑(trifluoromethyl)benzothiazole is the preferred scaffold when the CF₃ group must remain intact while introducing elaboration on the benzo ring.

In agrochemical lead discovery, the incorporation of the 2‑(trifluoromethyl)benzothiazole fragment into succinate dehydrogenase inhibitor (SDHI) pharmacophores yielded candidates with improved rain‑fastness and cuticular penetration. A prototype benzothiazole‑carboxamide (TX‑479) was evaluated in a glasshouse trial following EPPO PP1/26(4) guidelines against Phytophthora infestans on tomato cv. Moneymaker. Spray application at 150 g a.i. ha⁻¹ in 400 L water ha⁻¹ gave 92 % disease control 7 days post‑inoculation, whereas the 2‑methyl analogue achieved 78 %. Residue analysis of fruit sampled at harvest revealed levels below 0.01 mg kg⁻¹, compliant with EU MRL regulation (EC) No 396/2005. However, at rates exceeding 300 g a.i. ha⁻¹, transient chlorotic spotting appeared on young leaves, restricting the application window to the pre‑flowering stage. The enhanced performance is ascribed to the higher log P of the CF₃ derivative, which promotes partitioning into the waxy cuticle and reduces wash‑off by simulated rainfall (20 mm h⁻¹, 30 min after application, ISO 22030:2005). Field‑scale synthesis of TX‑479 routinely consumes multi‑kilogram lots of 2‑(trifluoromethyl)benzothiazole, with in‑process HPLC monitoring (C18 column, CH₃CN/H₂O 70:30, UV 254 nm) confirming purity above 99.0 % before acylation.

Photostability and Fluorescence Quantum Yield in Polymer‑Bound Sensor Arrays

In optoelectronic materials, 2‑(trifluoromethyl)benzothiazole serves as a strong electron‑accepting unit in donor–acceptor conjugated polymers. A polyfluorene derivative carrying pendant 2‑(trifluoromethyl)benzothiazole groups exhibited a Stern–Volmer quenching constant (K_SV) of 1.2 × 10⁴ M⁻¹ towards 2,4,6‑trinitrotoluene (TNT) in THF, compared with 4.5 × 10³ M⁻¹ for the 2‑methyl‑substituted polymer, as determined by steady‑state fluorescence (λ_exc = 380 nm, λ_em = 510 nm). Quantum yield values were referenced against quinine sulfate in 0.1 M H₂SO₄ (Φ = 0.546) according to ASTM E388‑04. Thin films spin‑coated onto quartz slides from chlorobenzene (2000 rpm, 30 s) detected TNT vapour at concentrations as low as 5 ppb, offering a 10‑fold sensitivity advantage over the non‑fluorinated comparator. The improved performance correlates with a lowering of the LUMO energy by 0.32 eV (calculated by DFT at the B3LYP/6‑31G* level), facilitating photo‑induced electron transfer from the polymer backbone to the nitroaromatic analyte. Long‑term photostability tests in a xenon‑arc weatherometer (irradiance 0.68 W m⁻² at 340 nm, black‑panel temperature 63 °C, ISO 4892‑2 cycle 1) revealed < 5 % loss in fluorescence intensity after 300 h, compared with a 20 % drop for the non‑fluorinated reference, demonstrating the protective effect of the electron‑withdrawing group against photobleaching.

Controlling Exothermic Events in Batch Trifluoromethylation: A Scale‑Up Perspective

Industrial manufacture of 2‑(trifluoromethyl)benzothiazole via the Cu‑mediated trifluoromethylation of 2‑aminobenzothiazole demands rigorous thermal hazard management. In a typical 500 L glass‑lined reactor, 2‑aminobenzothiazole (80 kg, 533 mol) is diazotised in hydrochloric acid with sodium nitrite below 0 °C; the resulting diazonium salt stream is then fed into a pre‑cooled solution of CuCF₃ generated in‑situ from CuBr, sodium trifluoroacetate, and tetramethylethylenediamine in DMF at –10 ± 2 °C. The dosing rate must not exceed 5 L min⁻¹. Pilot batch ADM‑204‑7B, in which the addition rate inadvertently reached 8 L min⁻¹, recorded a temperature spike of 12 °C above the setpoint; the adiabatic temperature rise later calculated from RC1e calorimetry was 45 K, with a time‑to‑maximum‑rate (TMR_ad) of 24 h at 30 °C, classifying the process as Stoessel criticality class 5. The resulting yield fell from 67 % to 41 % due to competitive Wurtz coupling that produced 2,2′‑bibenzothiazole as the dominant impurity. Routine production therefore employs an automated dosing system interlocked with a Pt100 probe, maintaining the internal temperature at –5 ± 2 °C. Post‑reaction, the crude product is fractionally distilled through a structured‑packing column (30 theoretical plates) under reduced pressure (20 mbar, head temperature 118 °C), which removes residual DMF and the low‑boiling difluoromethyl by‑product (bp 194 °C, identified by GC‑MS as the major impurity at 1.2 % before rectification). Product collected in the heart‑cut achieves a GC purity of  ≥ 98.5 %.

When formulated into self‑polishing copolymer coatings for marine antifouling, 2‑(trifluoromethyl)benzothiazole is added at 0.5–1.5 wt % as a non‑biocidal photostabiliser. Accelerated weathering in a QUV chamber following ASTM G154 cycle 1 (UVA‑340 lamps, 0.77 W m⁻² at 340 nm, 60 °C black‑panel temperature, 4 h UV / 4 h condensation) for 2000 h produced a weight‑average molecular weight loss of less than 5 % (GPC‑MALLS in THF) for the doped film, while the unmodified copolymer suffered a 15 % reduction. Adhesion pull‑off tests on aluminium panels after 1000 h salt‑spray exposure per ISO 9227 recorded a loss of pull‑off strength below 3 % (digital pull‑off tester, ASTM D4541), in contrast to a 12 % loss for the blank. Exceeding the 1.5 wt % threshold, however, induces phase separation visible as a haze increase of ΔHaze > 5 units (ASTM D1003), attributable to limited compatibility of the fluorinated additive with the acrylic backbone. Processing therefore requires pre‑dissolution in xylene with high‑shear mixing (rotor‑stator, 10 000 rpm, 15 min) before let‑down into the coating matrix.